EYE 1.35% 18.8¢ nova eye medical limited

CMS Proposes Major Increase in Reimbursement for Canaloplasty, page-403

  1. 5,073 Posts.
    lightbulb Created with Sketch. 552
    Thanks for your message. Looking forward to discussing the stock with whoever.

    After a rigorous analysis, which includes an exhaustive review of both fundamental and technical factors, along with a close examination of investor sentiment and discussions with industry insiders, it has become alarmingly clear that EYE is significantly overvalued. The current trading price far exceeds its true worth, and I foresee a sharp correction on the horizon, with the stock likely head towards its fair value range of $0.175 to $0.19.
    Last edited by stonks92: 11/08/24
 
watchlist Created with Sketch. Add EYE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.